Antiviral Treatment for Hepatitis C Virus and Risk of Hepatocellular Carcinoma

Module number
Date presented
February 13, 2018 
CE Credit

On Tuesday, February 13th, Dr. George Ioannou of the University of Washington presented on: “Antiviral treatment for hepatitis C virus and risk of hepatocellular carcinoma”

About Dr. Ioannou:
Dr. George Ioannou is the Director of Hepatology at the Veterans Affairs Puget Sound Healthcare System and an Associate Professor of Medicine at the University of Washington. He is also the co-Director of the VA Hepatitis C Innovation Team for VA Network 20 (VISN 20).
His research interests include epidemiological and clinical studies of hepatitis C, hepatocellular carcinoma and cirrhosis as well as liver transplant outcomes.

Access the slides here